|
Active substance |
trifluridine/tipiracil |
|
Holder |
Servier Benelux |
|
Status |
Closed |
|
Indication |
monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease. |
|
Public documents |
|
|
Last update |
05/10/2020 |
Lonsurf®
Last updated on 10/09/2024